Buy & Sell Eos Energy Enterprises Inc (EOSE) – Eos Energy Enterprises Inc Price Today
Aura AI Summary
Key Stats
- $2.33BMarket Cap
- EnergySector
- -61.72%3M Drawdown
- $2.57BEnterprise Value
- -Dividend Yield
- 70% Buy | 30% SellTrading Activity
- 7 daysTypical Hold Time
Eos Energy Enterprises Inc (EOSE) is currently valued at a market capitalization of $2.33B, with an enterprise value of $2.57B. Over the past 52 weeks, Eos Energy Enterprises Inc has traded between a low of $3.8 and a high of $19.19, highlighting its annual price range. Over the past three months, Eos Energy Enterprises Inc has recorded a drawdown of -61.72%, reflecting recent price volatility. On average, investors hold Eos Energy Enterprises Inc for approximately 7 days, indicating typical investor behavior on the platform.
About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Most Recent News
BC launches Outdoor Sector Coalition to boost economy, health, and conservation of its outdoors.
A coalition of over 2,000 organizations in British Columbia has formed to support the province's outdoor sector, which is a $17 billion industry employing 80,000 people. The coalition aims to enhance health benefits, support outdoor businesses, and p...

Nvidia's Q1 2027 earnings face high expectations amid strong past beats but mixed stock reactions.
Nvidia is set to report its Q1 2027 earnings with Wall Street expecting $78.8 billion in revenue and $1.77 EPS, marking record growth. Historically, Nvidia has consistently beaten revenue and EPS estimates, but recent earnings have shown that the sto...

ESR1-mutated metastatic breast cancer market to grow 9.6% CAGR with new oral SERDs and targeted therapies.
The ESR1-mutated metastatic breast cancer market is projected to grow rapidly at a 9.6% CAGR from 2026 to 2036, driven by rising cases of endocrine-resistant HR-positive/HER2-negative breast cancer and advances in precision oncology. Novel therapies ...
